ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 125 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $528,000 | -61.1% | 31,739 | -63.0% | 0.02% | -56.4% |
| Q2 2018 | $1,356,000 | +4.8% | 85,827 | -15.8% | 0.06% | +5.8% |
| Q1 2018 | $1,294,000 | +46.5% | 101,927 | +32.2% | 0.05% | +33.3% |
| Q4 2017 | $883,000 | -19.7% | 77,127 | -14.0% | 0.04% | -30.4% |
| Q3 2017 | $1,099,000 | +0.6% | 89,727 | +138.8% | 0.06% | +36.6% |
| Q4 2014 | $1,092,000 | +142.1% | 37,567 | +5.5% | 0.04% | +95.2% |
| Q3 2014 | $451,000 | – | 35,597 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |